Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

EW

Edwards Lifesciences Corp

Feb 12 • 04:00PM ET

76.44

-2.89 -3.64 %

Healthcare • Medical Devices • USA • NYSE

Peers: MDT ABT BSX SYK ISRG ZBH TFX COO ALGN

| Held by: VTI VOO VO IVV SPY VTV VOT XLV IHI RSP

Index	S&P 500	P/E	41.26	EPS (ttm)	1.85	Insider Own	1.37%	Shs Outstand	580.30M	Perf Week	-2.13%
Market Cap	44.36B	Forward P/E	23.05	EPS next Y	3.32	Insider Trans	-1.24%	Shs Float	572.36M	Perf Month	-8.83%
Enterprise Value	41.96B	PEG	1.72	EPS next Q	0.73	Inst Own	87.88%	Short Float	1.41%	Perf Quarter	-10.24%
Income	1.09B	P/S	7.31	EPS this Y	15.78%	Inst Trans	-1.62%	Short Ratio	2.13	Perf Half Y	-1.60%
Sales	6.07B	P/B	4.35	EPS next Y	11.91%	ROA	10.23%	Short Interest	8.09M	Perf YTD	-10.33%
Book/sh	17.57	P/C	14.79	EPS next 5Y	13.39%	ROE	13.59%	52W High	87.89 -13.03%	Perf Year	0.82%
Cash/sh	5.17	P/FCF	55.16	EPS past 3/5Y	-9.12% 7.03%	ROIC	9.99%	52W Low	65.94 15.92%	Perf 3Y	-0.98%
Dividend Est.	-	EV/EBITDA	23.86	Sales past 3/5Y	4.08% 6.70%	Gross Margin	79.71%	Volatility	3.69% 2.72%	Perf 5Y	-12.79%
Dividend TTM	-	EV/Sales	6.92	EPS Y/Y TTM	26.82%	Oper. Margin	26.75%	ATR (14)	2.27	Perf 10Y	182.97%
Dividend Ex-Date	-	Quick Ratio	3.29	Sales Y/Y TTM	6.00%	Profit Margin	17.92%	RSI (14)	34.22	Recom	1.79
Dividend Gr. 3/5Y	- -	Current Ratio	4.00	EPS Q/Q	-75.99%	SMA20	-6.16%	Beta	0.95	Target Price	96.93
Payout	0.00%	Debt/Eq	0.06	Sales Q/Q	13.26%	SMA50	-8.49%	Rel Volume	1.43	Prev Close	79.33
Employees	15800	LT Debt/Eq	0.06	Earnings	Feb 10 AMC	SMA200	-3.94%	Avg Volume	3.81M	Price	76.44
IPO	Mar 27, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	-6.13% 1.47%	Trades		Volume	5,382,620	Change	-3.64%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-09-26	Upgrade	TD Cowen	Hold → Buy	$97
Dec-18-25	Upgrade	JP Morgan	Neutral → Overweight	$100
Nov-03-25	Upgrade	Raymond James	Mkt Perform → Outperform	$96
Oct-29-25	Upgrade	Wolfe Research	Underperform → Peer Perform
Oct-29-25	Upgrade	Jefferies	Hold → Buy	$98
Oct-08-25	Downgrade	Oppenheimer	Outperform → Perform
Oct-07-25	Upgrade	Evercore ISI	In-line → Outperform	$88
Jul-29-25	Upgrade	BTIG Research	Neutral → Buy	$100
Apr-24-25	Upgrade	Piper Sandler	Neutral → Overweight	$80
Jan-30-25	Upgrade	Stifel	Hold → Buy	$75 → $90
Jan-16-25	Downgrade	Wolfe Research	Peer Perform → Underperform	$60
Dec-16-24	Upgrade	BofA Securities	Neutral → Buy
Oct-11-24	Resumed	Morgan Stanley	Equal-Weight	$70
Sep-18-24	Downgrade	Jefferies	Buy → Hold	$85 → $70
Jul-31-24	Upgrade	Daiwa Securities	Neutral → Outperform
Jul-29-24	Upgrade	Wolfe Research	Underperform → Peer Perform
Jul-25-24	Downgrade	Truist	Buy → Hold	$110 → $82
Jul-25-24	Downgrade	TD Cowen	Buy → Hold	$100 → $70
Jul-25-24	Downgrade	Robert W. Baird	Outperform → Neutral	$102 → $70
Jul-25-24	Downgrade	JP Morgan	Overweight → Neutral	$105 → $72

Show Previous Ratings

Today 07:57AM	BSX Posts Q4 Earnings: Should You Buy, Sell or Hold the Stock? (Zacks)
07:05AM	Edwards Lifesciences to Present at Citi's 2026 Unplugged Medtech and Life Sciences Access Day (Business Wire)
Feb-12-26 01:26PM	A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH (MarketBeat)
Feb-11-26 05:02PM	Options Corner: Edwards Lifesciences Poor Start To The New Year Offers A Contrarian Opportunity (Benzinga)
04:07PM	Edwards Wavers Analysts Debate Its Earnings Miss Amid Hefty TAVR Investments (Investor's Business Daily)
11:00AM	Loading…
11:00AM	Edwards Slips As Analysts Debate Its Earnings Miss Amid Hefty TAVR Investments (Investor's Business Daily)
08:30AM	Edwards Lifesciences Corporation Q4 2025 Earnings Call Summary (Moby)
08:17AM	EW's Q4 Earnings Miss Estimates, Revenues Up Y/Y, Stock Climbs (Zacks)
07:44AM	Edwards reports strong 2025 despite Q4 EPS miss (Medical Device Network)
01:24AM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
12:01AM	Edwards Lifesciences Corp (EW) Q4 2025 Earnings Call Highlights: Strong Sales Growth Amidst ... (GuruFocus.com)
Feb-10-26 10:07PM	Edwards Lifesciences Q4 Earnings Call Highlights (MarketBeat)
06:00PM	Compared to Estimates, Edwards Lifesciences (EW) Q4 Earnings: A Look at Key Metrics (Zacks)
04:46PM	Edwards Lifesciences Pops On Its Bullish 2026 View Despite Mixed Fourth Quarter (Investor's Business Daily)
04:29PM	Edwards Lifesciences Comes Up Mixed, But Offers A Bullish 2026 View (Investor's Business Daily)
04:15PM	Loading…
04:15PM	Edwards Lifesciences Reports Fourth Quarter Results (Business Wire)
Feb-09-26 02:08PM	MedTech Stocks to Report Earnings on Feb. 10: DGX, ZBH & EW (Zacks)
09:47AM	What Are Wall Street Analysts' Target Price for Edwards Lifesciences Stock? (Barchart)
Feb-06-26 08:15AM	The TAVR Pioneer Bets Everything on One Market as Its Competitor Spreads Risk (24/7 Wall St.)
Feb-05-26 09:15AM	Ahead of Edwards Lifesciences (EW) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
Feb-04-26 10:23AM	Edwards Lifesciences' Q4 Earnings on Deck: Here's What to Expect (Zacks)
Feb-03-26 07:05AM	Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026 (Business Wire)
Feb-02-26 09:51PM	Edwards Lifesciences Corporation (EW): A Bull Case Theory (Insider Monkey)
07:05AM	Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference (Business Wire)
Jan-31-26 09:35AM	Analyst Upgrades Signal Renewed Growth Cycle for Edwards Lifesciences Corporation (EW) (Insider Monkey)
Jan-30-26 02:31PM	Renewed Growth Cycle Drives a Favorable Sentiment Towards Edwards Lifesciences (EW) (Insider Monkey)
Jan-26-26 05:06AM	Intuitives cardiac initiative includes valve repair, LAA closure (MedTech Dive)
Jan-25-26 11:44AM	Beyond Biotech-3 Healthcare Stocks for Growth-Minded Investors (MarketBeat)
Jan-19-26 09:25AM	Does Edwards Lifesciences (EW) Have Strong Double-Digit Earnings Potential? (Insider Monkey)
Jan-15-26 08:42AM	Boston Scientific Acquires Penumbra In $14.5 Billion Bet To Dominate Thrombectomy (Benzinga)
01:19PM	Loading…
Jan-14-26 01:19PM	JPM26: Edwards Lifesciences targets 10% growth in 2026 (Medical Device Network)
07:50AM	Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now? (Zacks)
Jan-13-26 09:01AM	What to Expect From Edwards Lifesciences' Q4 2025 Earnings Report (Barchart)
Jan-12-26 09:31AM	Court Ruling Ends Edwards Lifesciences $1.2 Billion Plan To Acquire JenaValve (Benzinga)
07:38AM	Edwards JenaValve acquisition nixed as FTC injunction approved by court (Medical Device Network)
05:37AM	Edwards calls off JenaValve buyout after court halts deal (MedTech Dive)
Jan-09-26 06:48PM	Edwards Comments on JenaValve Acquisition (Business Wire)
Dec-26-25 12:20PM	EW Wins FDA Approval for SAPIEN M3 as First Transseptal TMVR Therapy (Zacks)
Dec-24-25 12:45PM	HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
08:40AM	How Well Is Boston Scientific Placed for Long-Term Endoscopy Growth? (Zacks)
Dec-23-25 10:21AM	The Zacks Analyst Blog Highlights Cardinal Health, Medtronic, Intuitive Surgical and Edwards Lifesciences (Zacks)
09:00AM	FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy (Business Wire)
Dec-22-25 11:07AM	4 Large-Cap MedTech Stocks to Keep Winning Streaks Alive in 2026 (Zacks)
Dec-18-25 07:05AM	Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-11-25 08:09AM	Should You Continue to Hold EW Stock in Your Portfolio? (Zacks)
Dec-04-25 09:00AM	Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference (Business Wire)
Dec-03-25 12:45PM	Cooper Companies to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
Dec-02-25 03:57AM	How Is Edwards Lifesciences Stock Performance Compared to Other Medical Device Stocks? (Barchart)
Nov-30-25 03:29PM	HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
Nov-24-25 08:25AM	BSX vs. EW: Which Heart Device Stock Is the Smarter Investment Now? (Zacks)
Nov-11-25 05:58AM	Edwards Lifesciences Stock: Is Wall Street Bullish or Bearish? (Barchart)
Nov-09-25 04:00PM	Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease (Business Wire)
Nov-07-25 01:23PM	Top Analyst Reports for JPMorgan Chase, Salesforce & Arista Networks (Zacks)
Nov-05-25 01:59PM	Do Options Traders Know Something About Edwards Lifesciences Stock We Don't? (Zacks)
10:27AM	Is the Options Market Predicting a Spike in Edwards Lifesciences Stock? (Zacks)
Oct-31-25 07:35PM	Closing Bell Movers: Amazon soars to all-time highs on earnings (TipRanks)
04:25PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
04:12PM	The 'Halo Effect' Bolstering Edwards Lifesciences' Biggest Moneymaker (Investor's Business Daily)
11:59AM	Edwards CFO Scott Ullem to exit post (MedTech Dive)
10:51AM	Demographic Megatrend: Stocks Poised to Benefit From Global Aging (Zacks)
10:17AM	EW Stock Gains on Q3 Earnings and Revenue Beat, Margins Crash (Zacks)
07:56AM	Edwards boosts FY25 outlook after Q3 surpasses expectations (Medical Device Network)
Oct-30-25 11:05PM	Edwards Lifesciences Corp (EW) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
06:00PM	Edwards Lifesciences (EW) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:24PM	Edwards Jumps On Beat-And-Raise, Announces CFO Transition (Investor's Business Daily)
04:15PM	Edwards Lifesciences Announces CFO Transition Plan (Business Wire)
04:13PM	Edwards Lifesciences Reports Third Quarter Results (Business Wire)
Oct-29-25 09:35AM	Skyworks upgraded, UnitedHealth downgraded: Wall Street's top analyst calls (The Fly)
Oct-28-25 09:37AM	Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their Rights (Business Wire)
09:15AM	Exploring Analyst Estimates for Edwards Lifesciences (EW) Q3 Earnings, Beyond Revenue and EPS (Zacks)
Oct-27-25 03:06PM	Successful Patient Outcomes Demonstrated With Edwards' SAPIEN M3 and EVOQUE Systems, New Data Presented at TCT 2025 (Business Wire) +6.20%
02:22PM	Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025 (Business Wire)
10:00AM	Idexx Laboratories (IDXX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-24-25 09:00AM	Will SYK's Q3 Results Reflect MedSurg Strength & Rebound in Orthopaedics? (Zacks)
Oct-23-25 07:53AM	Will RVTY Q3 Earnings Reflect Segmental Strength Amid Rising Demand? (Zacks)
07:05AM	Edwards Lifesciences to Host Earnings Conference Call on October 30, 2025 (Business Wire)
Oct-21-25 06:33AM	Piper Sandler Maintains Overweight on Edwards Lifesciences (EW) Ahead of PARTNER 3 7-Year Results (Insider Monkey)
Oct-17-25 09:08AM	WST Q3 Earnings Preview: Can GLP-1 Momentum Outweigh Margin Pressure? (Zacks)
08:26AM	Robust TAVR Growth to Drive Edwards Lifesciences' Q3 Earnings (Zacks)
Oct-13-25 08:14AM	Pulse Biosciences Unveils Promising First-in-Human Data for nPulse (Zacks)
Oct-10-25 08:44AM	Abbott to Report Q3 Earnings: Medical Devices Arm in Focus (Zacks)
Oct-08-25 11:16AM	TLRY Gears Up to Report Q1 Earnings: Cannabis Recovery in Focus (Zacks)
09:45AM	Intel, FedEx downgraded: Wall Street's top analyst calls (The Fly)
Oct-07-25 09:50AM	Netflix upgraded, Dollar Tree downgraded: Wall Street's top analyst calls (The Fly)
Oct-06-25 07:58AM	Here's What to Expect From Edwards Lifesciences Next Earnings Report (Barchart)
Oct-02-25 07:10AM	AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
Sep-19-25 04:02PM	Edwards Lifesciences Corporation (EW): A Bull Case Theory (Insider Monkey)
Sep-10-25 04:52AM	Edwards Lifesciences Corporation (EW) Welcomes Newly Updated ESC/EACTS Guidelines for Severe Aortic Stenosis (AS) (Insider Monkey)
Sep-09-25 11:44AM	Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings (Motley Fool)
Sep-05-25 12:21PM	Edwards Lifesciences TAVR growth continues as global demand rises (Medical Device Network)
Sep-04-25 04:29PM	Top Stock Reports for Apple, Novartis & Charles Schwab (Zacks)
Sep-03-25 05:55AM	Edwards, Medtronic and Abbott stand to benefit from new TAVR guidelines in Europe (MedTech Dive)
Sep-02-25 11:13AM	Leerink Partners Lifts Edwards Lifesciences (EW) Price Target Amid Buybacks Focus (Insider Monkey)
06:51AM	Edwards Lifesciences Stock: Is EW Outperforming the Healthcare Sector? (Barchart)
Sep-01-25 12:20PM	3 Healthcare Pathbreakers With Long-Term Tailwinds (MarketBeat)
11:51AM	ESC 2025: Structural heart disease guidelines updated following Edwards trial results (Medical Device Network)
Aug-29-25 09:48AM	ABT vs. EW: Which Structural Heart Device Stock Is Worth Buying Now? (Zacks)
09:09AM	Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care (Business Wire)
Aug-21-25 02:10PM	Edwards Lifesciences Stock Pumps Up Its Relative Strength Rating (Investor's Business Daily)
Aug-19-25 04:15PM	Edwards Lifesciences Announces $500 Million Accelerated Share Repurchase (Business Wire)

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Zovighian Bernard J	Officer	Feb 12 '26	Proposed Sale	76.67	22,430	1,719,742		Feb 12 04:54 PM
Lippis Daniel J.	CVP, TAVR	Jan 09 '26	Option Exercise	59.26	1,019	60,383	23,021	Jan 09 05:41 PM
Lippis Daniel J.	CVP, TAVR	Jan 09 '26	Sale	85.70	1,019	87,332	22,002	Jan 09 05:41 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jan 06 '26	Option Exercise	59.26	11,340	671,971	43,210	Jan 06 06:02 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jan 06 '26	Sale	85.66	11,340	971,429	31,870	Jan 06 06:02 PM
BOBO DONALD E JR	Officer	Jan 06 '26	Proposed Sale	85.66	45,360	3,885,715		Jan 06 04:04 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 12 '25	Sale	83.76	11,386	953,748	38,970	Dec 12 05:57 PM
Lippis Daniel J.	CVP, JAPAC	Dec 12 '25	Option Exercise	59.26	1,019	60,383	23,021	Dec 12 05:57 PM
Lippis Daniel J.	CVP, JAPAC	Dec 12 '25	Sale	84.03	1,019	85,625	22,002	Dec 12 05:57 PM
STONE HEISZ LESLIE	Director	Dec 12 '25	Sale	83.41	2,615	218,120	30,948	Dec 12 05:57 PM
BOBO JR FAMILY TRUST	Officer	Dec 12 '25	Proposed Sale	83.74	5,900	494,066		Dec 12 04:22 PM
STONE HEISZ LESLIE	Director	Dec 12 '25	Proposed Sale	83.41	2,615	218,119		Dec 12 04:04 PM
BOBO DONALD E JR	Officer	Dec 12 '25	Proposed Sale	83.78	5,487	459,682		Dec 12 04:03 PM
Chopra Daveen	CVP, TMTT & Surgical	Dec 11 '25	Sale	84.38	2,000	168,750	32,201	Dec 11 05:58 PM
Chopra Daveen	Officer	Dec 11 '25	Proposed Sale	84.38	2,000	168,750		Dec 11 04:01 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 10 '25	Option Exercise	59.26	11,340	671,971	61,696	Dec 10 06:58 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 10 '25	Sale	83.83	11,340	950,581	50,356	Dec 10 06:58 PM
Zovighian Bernard J	CEO	Dec 08 '25	Option Exercise	59.26	25,350	1,502,157	106,326	Dec 10 06:58 PM
Zovighian Bernard J	CEO	Dec 08 '25	Sale	85.21	21,487	1,831,006	84,839	Dec 10 06:58 PM
Zovighian Bernard J	CEO	Dec 10 '25	Sale	83.45	3,863	322,367	8,597	Dec 10 06:58 PM
BOBO DONALD E JR	Officer	Dec 10 '25	Proposed Sale	83.83	11,340	950,582		Dec 10 04:38 PM
Zovighian Bernard J	Officer	Dec 10 '25	Proposed Sale	83.45	3,863	322,367		Dec 10 04:37 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 09 '25	Option Exercise	59.26	7,700	456,277	47,598	Dec 09 05:01 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 09 '25	Sale	84.47	7,700	650,412	39,898	Dec 09 05:01 PM
Markowitz Wayne	CVP, JAPAC	Dec 08 '25	Sale	86.01	583	50,144	17,563	Dec 08 05:50 PM
Markowitz Wayne	Officer	Dec 08 '25	Proposed Sale	86.01	583	50,144		Dec 08 04:13 PM
Zovighian Bernard J	Officer	Dec 08 '25	Proposed Sale	85.21	21,487	1,831,006		Dec 08 04:12 PM
Wood Larry L	Former Affiliate	Nov 11 '25	Proposed Sale	85.12	26,850	2,285,355		Nov 12 01:30 PM
Ullem Scott B.	CVP, Chief Financial Officer	Nov 10 '25	Option Exercise	59.26	13,000	770,337	52,898	Nov 10 06:07 PM
Ullem Scott B.	CVP, Chief Financial Officer	Nov 10 '25	Sale	83.08	13,000	1,080,093	39,898	Nov 10 06:07 PM
Lippis Daniel J.	CVP, JAPAC	Nov 10 '25	Option Exercise	59.26	1,020	60,442	23,022	Nov 10 06:06 PM
Lippis Daniel J.	CVP, JAPAC	Nov 10 '25	Sale	82.55	1,020	84,196	22,002	Nov 10 06:06 PM
Lippis Daniel J.	Officer	Nov 10 '25	Proposed Sale	82.55	3,058	252,423		Nov 10 04:08 PM
Ullem Scott B.	Officer	Nov 10 '25	Proposed Sale	83.08	20,700	1,719,841		Nov 10 04:07 PM
Wood Larry L	Former Affiliate	Oct 16 '25	Proposed Sale	73.02	8,950	653,522		Oct 16 04:07 PM
Chopra Daveen	CVP, TMTT	Aug 25 '25	Sale	81.95	2,500	204,865	30,996	Aug 25 06:25 PM
Chopra Daveen	Officer	Aug 25 '25	Proposed Sale	81.95	2,500	204,865		Aug 25 04:15 PM
Wood Larry L	Global President TAVR & Surg	Aug 18 '25	Option Exercise	59.26	8,950	530,347	215,850	Aug 18 06:11 PM
Wood Larry L	Global President TAVR & Surg	Aug 18 '25	Sale	78.06	8,950	698,679	206,900	Aug 18 06:11 PM
Wood Larry L	Officer	Aug 18 '25	Proposed Sale	78.06	8,950	698,679		Aug 18 04:29 PM
Lippis Daniel J.	CVP, JAPAC	Jul 28 '25	Sale	79.46	4,114	326,900	22,002	Jul 28 06:23 PM
Lippis Daniel J.	Officer	Jul 28 '25	Proposed Sale	79.46	4,114	326,900		Jul 28 04:04 PM
Wood Larry L	Global President TAVR & Surg	Jun 16 '25	Option Exercise	59.26	8,950	530,347	215,850	Jun 16 05:09 PM
Wood Larry L	Global President TAVR & Surg	Jun 16 '25	Sale	75.23	8,950	673,268	206,900	Jun 16 05:09 PM
Wood Larry L	Officer	Jun 16 '25	Proposed Sale	75.23	8,950	673,268		Jun 16 04:20 PM
Zovighian Bernard J	CEO	May 30 '25	Sale	77.21	16,099	1,243,065	9,564	Jun 03 05:15 PM
Zovighian Bernard J	CEO	Jun 03 '25	Sale	77.32	967	74,772	8,597	Jun 03 05:15 PM
Zovighian Bernard J	Officer	Jun 03 '25	Proposed Sale	77.32	967	74,772		Jun 03 04:29 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jun 02 '25	Sale	77.40	2,570	198,911	50,356	Jun 02 05:01 PM
BOBO DONALD E JR	Officer	Jun 02 '25	Proposed Sale	77.40	2,570	198,911		Jun 02 04:03 PM
Zovighian Bernard J	Officer	May 30 '25	Proposed Sale	77.21	16,099	1,243,064		May 30 04:31 PM
Chopra Daveen	CVP, TMTT	May 22 '25	Sale	75.08	1,500	112,612	33,496	May 22 05:08 PM
Chopra Daveen	Officer	May 22 '25	Proposed Sale	75.07	1,500	112,612		May 22 04:01 PM
Lippis Daniel J.	CVP, JAPAC	May 09 '25	Option Exercise	45.28	330	14,941	26,946	May 09 07:35 PM
Lippis Daniel J.	CVP, JAPAC	May 09 '25	Sale	74.42	330	24,560	26,616	May 09 07:35 PM
Markowitz Wayne	GM & SVP, Surgical	May 07 '25	Sale	75.08	268	20,121	9,299	May 09 07:34 PM
Ullem Scott B.	CVP, Chief Financial Officer	May 09 '25	Option Exercise	45.28	11,250	509,363	52,348	May 09 07:34 PM
Ullem Scott B.	CVP, Chief Financial Officer	May 09 '25	Sale	74.40	11,250	837,035	41,098	May 09 07:34 PM
Lippis Daniel J.	Officer	May 09 '25	Proposed Sale	74.42	330	24,560		May 09 04:00 PM
Markowitz Wayne	Officer	May 07 '25	Proposed Sale	75.08	268	20,121		May 07 04:48 PM
Zovighian Bernard J	CEO	May 05 '25	Option Exercise	45.28	7,462	337,855	65,746	May 06 05:13 PM
Zovighian Bernard J	CEO	May 05 '25	Sale	74.91	5,980	447,977	58,284	May 06 05:13 PM
Zovighian Bernard J	Officer	May 05 '25	Proposed Sale	74.91	5,980	447,977		May 05 04:03 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Apr 14 '25	Option Exercise	45.28	9,500	430,129	56,706	Apr 14 06:18 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Apr 14 '25	Sale	69.81	9,500	663,196	47,206	Apr 14 06:18 PM
Lippis Daniel J.	CVP, JAPAC	Apr 08 '25	Option Exercise	45.28	300	13,583	23,163	Apr 08 05:12 PM
Lippis Daniel J.	CVP, JAPAC	Apr 08 '25	Sale	70.61	300	21,183	22,863	Apr 08 05:12 PM
Lippis Daniel J.	Officer	Apr 08 '25	Proposed Sale	70.61	300	21,183		Apr 08 04:19 PM
Ullem Scott B.	CVP, Chief Financial Officer	Mar 26 '25	Option Exercise	45.28	11,250	509,363	41,637	Mar 26 04:45 PM
Ullem Scott B.	CVP, Chief Financial Officer	Mar 26 '25	Sale	70.87	11,250	797,267	30,387	Mar 26 04:45 PM
Ullem Scott B.	Officer	Mar 26 '25	Proposed Sale	70.87	22,500	1,594,534		Mar 26 04:14 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Mar 13 '25	Option Exercise	45.28	9,500	430,129	56,436	Mar 13 05:41 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Mar 13 '25	Sale	67.96	9,500	645,624	46,936	Mar 13 05:41 PM
Zovighian Bernard J	CEO	Mar 10 '25	Option Exercise	45.28	7,463	337,900	66,546	Mar 10 07:35 PM
Zovighian Bernard J	CEO	Mar 10 '25	Sale	69.51	6,164	428,448	59,083	Mar 10 07:35 PM
Lippis Daniel J.	CVP, JAPAC	Mar 10 '25	Option Exercise	45.28	400	18,111	22,988	Mar 10 07:34 PM
Lippis Daniel J.	CVP, JAPAC	Mar 10 '25	Sale	69.48	400	27,792	22,588	Mar 10 07:34 PM
Zovighian Bernard J	Officer	Mar 10 '25	Proposed Sale	69.51	6,164	428,448		Mar 10 04:13 PM
Lippis Daniel J.	Officer	Mar 10 '25	Proposed Sale	69.48	400	27,792		Mar 10 04:13 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 28 '25	Option Exercise	45.28	11,250	509,363	41,637	Feb 28 05:05 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 28 '25	Sale	70.78	11,250	796,327	30,387	Feb 28 05:05 PM
LORANGER STEVEN R	Director	Feb 14 '25	Option Exercise	45.32	5,739	260,073	66,111	Feb 14 04:41 PM
LORANGER STEVEN R	Director	Feb 14 '25	Sale	76.42	5,739	438,576	60,372	Feb 14 04:41 PM
LORANGER STEVEN R	Director	Feb 14 '25	Proposed Sale	76.42	5,739	438,576		Feb 14 04:11 PM

Open in Screener

NVST

Envista Holdings Corp

Feb 12 • 04:00PM ET

28.77

-1.49 -4.92 %

Healthcare • Medical Instruments & Supplies • USA • NYSE

NVST Envista Holdings Corp daily Stock Chart

Peers: ALGN XRAY PDCO HSIC ABT BDX SYK STE ZBH ISRG

| Held by: IJH VTI VB VBR VXF MDY XMHQ DFAT FNDA IJJ

Index	-	P/E	104.66	EPS (ttm)	0.27	Insider Own	2.24%	Shs Outstand	163.80M	Perf Week	16.43%
Market Cap	4.73B	Forward P/E	18.45	EPS next Y	1.56	Insider Trans	-0.67%	Shs Float	160.74M	Perf Month	23.85%
Enterprise Value	5.12B	PEG	1.39	EPS next Q	0.31	Inst Own	112.47%	Short Float	5.03%	Perf Quarter	42.36%
Income	47.00M	P/S	1.74	EPS this Y	18.51%	Inst Trans	-3.69%	Short Ratio	3.04	Perf Half Y	33.44%
Sales	2.72B	P/B	1.52	EPS next Y	10.54%	ROA	0.84%	Short Interest	8.09M	Perf YTD	32.52%
Book/sh	18.96	P/C	3.90	EPS next 5Y	13.29%	ROE	1.56%	52W High	30.42 -5.42%	Perf Year	37.92%
Cash/sh	7.37	P/FCF	20.53	EPS past 3/5Y	-40.82% 6.49%	ROIC	1.01%	52W Low	14.22 102.32%	Perf 3Y	-27.95%
Dividend Est.	-	EV/EBITDA	14.34	Sales past 3/5Y	1.91% 7.11%	Gross Margin	55.02%	Volatility	5.32% 4.03%	Perf 5Y	-28.70%
Dividend TTM	-	EV/Sales	1.88	EPS Y/Y TTM	104.28%	Oper. Margin	8.85%	ATR (14)	1.13	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.04	Sales Y/Y TTM	8.32%	Profit Margin	1.73%	RSI (14)	69.17	Recom	2.20
Dividend Gr. 3/5Y	- -	Current Ratio	2.38	EPS Q/Q	2772.46%	SMA20	13.16%	Beta	0.94	Target Price	28.46
Payout	0.00%	Debt/Eq	0.51	Sales Q/Q	14.96%	SMA50	23.07%	Rel Volume	1.66	Prev Close	30.26
Employees	12300	LT Debt/Eq	0.50	Earnings	Feb 05 AMC	SMA200	39.49%	Avg Volume	2.66M	Price	28.77
IPO	Sep 18, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.61% 10.39%	Trades		Volume	4,347,508	Change	-4.92%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-06-26	Upgrade	Leerink Partners	Market Perform → Outperform	$35
Dec-09-25	Initiated	Barclays	Overweight	$24
May-27-25	Upgrade	Robert W. Baird	Neutral → Outperform	$23
Dec-04-24	Initiated	Mizuho	Underperform	$20
Oct-31-24	Upgrade	Leerink Partners	Underperform → Market Perform	$16 → $23
Oct-08-24	Initiated	Wells Fargo	Equal Weight	$20
Aug-08-24	Downgrade	JP Morgan	Overweight → Neutral	$23 → $16
Apr-26-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$33 → $21
Feb-26-24	Initiated	Leerink Partners	Underperform	$19
Feb-09-24	Downgrade	Jefferies	Buy → Hold	$30 → $23
Feb-08-24	Downgrade	William Blair	Outperform → Mkt Perform
Jan-05-24	Initiated	UBS	Neutral	$26
Dec-11-23	Downgrade	Goldman	Buy → Sell	$22
Nov-16-23	Initiated	Needham	Hold
Nov-02-23	Downgrade	Piper Sandler	Overweight → Neutral	$39 → $25
Aug-29-22	Upgrade	Piper Sandler	Neutral → Overweight	$40 → $46
Jun-14-22	Downgrade	Robert W. Baird	Outperform → Neutral	$54 → $46
Jan-31-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$48
Oct-26-21	Upgrade	BofA Securities	Neutral → Buy	$49 → $48
Aug-05-21	Resumed	Credit Suisse	Outperform	$55

Show Previous Ratings

Feb-12-26 09:36AM	Zacks.com featured highlights include Jacobs Solutions, Envista Holdings and and Tapestry (Zacks)
09:23AM	Envista Stock Rises Post Q4 Earnings & Revenue Beat, Gross Margin Down (Zacks)
08:24AM	Illumina Q4 Earnings & Revenues Top Estimates, Stock Dips (Zacks)
07:59AM	Best Growth Stocks to Buy for February 12th (Zacks)
12:40AM	5 Must-Read Analyst Questions From Envista's Q4 Earnings Call (StockStory)
09:27AM	Loading…
Feb-11-26 09:27AM	3 Stocks With Upgraded Broker Ratings to Buy Amid AI-Related Headwinds (Zacks)
08:17AM	EW's Q4 Earnings Miss Estimates, Revenues Up Y/Y, Stock Climbs (Zacks)
Feb-10-26 11:43AM	CVS Beats on Q4 Earnings and Revenues but Shares Slide in Pre-Market (Zacks)
11:11AM	ZBH Q4 Earnings & Revenues Top Estimates, Stock Up in Pre-Market (Zacks)
10:43AM	Quest Diagnostics' Q4 Earnings & Revenues Beat Estimates, Stock Up (Zacks)
09:45AM	Here's Why Envista (NVST) is a Strong Growth Stock (Zacks)
Feb-09-26 12:20PM	Surging Earnings Estimates Signal Upside for Envista (NVST) Stock (Zacks)
12:00PM	Envista (NVST) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
09:50AM	Here's Why Envista (NVST) is a Strong Momentum Stock (Zacks)
09:15AM	Envista Holdings Corporation (NVST) Hit a 52 Week High, Can the Run Continue? (Zacks)
04:46AM	Loading…
04:46AM	Best Momentum Stock to Buy for February 9th (Zacks)
Feb-07-26 10:20AM	Envista price target raised to $32 from $28 at BofA (TipRanks)
06:48AM	Envista (NVST) Climbs 23% on Swing to Profit (Insider Monkey)
Feb-06-26 10:08PM	Envista Q4 Earnings Call Highlights (MarketBeat) +17.77%
02:55PM	NVST Q4 Deep Dive: Broad-Based Growth and Margins Lift Outlook for 2026 (StockStory)
01:25PM	Tech Bounces As Software Sell-Off Eases, Dow Jones Hits Records: What's Moving Markets Friday? (Benzinga)
11:55AM	Why Envista (NVST) Stock Is Trading Up Today (StockStory)
12:01AM	Envista Holdings Corp (NVST) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Feb-05-26 07:30PM	Envista (NVST) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:55PM	Envista (NVST) Tops Q4 Earnings and Revenue Estimates (Zacks)
04:53PM	Envista: Q4 Earnings Snapshot (Associated Press Finance)
04:09PM	Envista (NYSE:NVST) Beats Expectations in Strong Q4 CY2025 (StockStory)
04:05PM	Envista Reports Fourth Quarter 2025 Results (PR Newswire)
09:40AM	Envista (NVST) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
Feb-03-26 10:15PM	Envista (NVST) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
11:40AM	Loading…
Feb-02-26 11:40AM	NVST or ABT: Which Is the Better Value Stock Right Now? (Zacks)
Jan-21-26 08:01AM	Here's Why You Should Hold Bio-Rad Stock in Your Portfolio Now (Zacks)
07:54AM	Is IDEXX Laboratories Stock the Right Pick for Your Portfolio Now? (Zacks)
Jan-20-26 08:36AM	Should You Still Hold GMED Stock in Your Portfolio? (Zacks)
Jan-15-26 11:40AM	NVST vs. SYK: Which Stock Is the Better Value Option? (Zacks)
09:42AM	Is it Apt to Retain HAE Stock in Your Portfolio for Now? (Zacks)
08:24AM	BSX Stock May Gain From Newly Inked Deal to Buy Valencia Technologies (Zacks)
Jan-14-26 07:50AM	Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now? (Zacks)
07:19AM	Should You Continue to Hold Thermo Fisher Stock in Your Portfolio Now? (Zacks)
Jan-08-26 04:20PM	Envista Schedules Fourth Quarter 2025 Earnings Call (PR Newswire)
Jan-07-26 04:15PM	Envista to Present at the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
07:35AM	Here's Why You Should Add NVST Stock to Your Portfolio Right Now (Zacks)
Dec-30-25 10:32PM	Dental Equipment & Technology Q3 Earnings: Envista (NYSE:NVST) Simply the Best (StockStory)
11:40AM	NVST vs. SYK: Which Stock Should Value Investors Buy Now? (Zacks)
Dec-11-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Dec-09-25 11:21AM	Envista (NVST) Stock Trades Up, Here Is Why (StockStory)
Dec-05-25 11:30AM	Why Is Zimmer (ZBH) Up 5.3% Since Last Earnings Report? (Zacks)
Nov-28-25 09:50AM	Here's Why Envista (NVST) is a Strong Momentum Stock (Zacks)
Nov-25-25 04:20PM	Envista Announces Participation in 8th Annual Evercore Healthcare Conference (PR Newswire)
Nov-24-25 09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
Nov-21-25 06:45PM	Envista, Alignment Healthcare, LifeStance Health Group, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know (StockStory)
Nov-06-25 12:34AM	5 Insightful Analyst Questions From Envista's Q3 Earnings Call (StockStory)
Nov-04-25 11:01PM	3 Reasons to Avoid NVST and 1 Stock to Buy Instead (StockStory)
Oct-31-25 09:40AM	Envista (NVST) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
08:47AM	NVST Q3 Deep Dive: Product Launches and Operational Gains Drive Margin Expansion (StockStory)
Oct-30-25 11:07PM	Envista Holdings Corp (NVST) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
10:24AM	Envista (NYSE:NVST) Surprises With Strong Q3 (StockStory)
05:04AM	Envista: Q3 Earnings Snapshot (Associated Press Finance)
Oct-29-25 08:28PM	Envista Reports Third Quarter 2025 Results (PR Newswire)
04:15PM	Envista Announces Release of 2024 Sustainability Report (PR Newswire)
Oct-28-25 11:02PM	Envista (NVST) Reports Earnings Tomorrow: What To Expect (StockStory)
Oct-23-25 12:42PM	Will Lower Patient Days Affect Tenet Healthcare's Q3 Earnings? (Zacks)
10:00AM	Envista (NVST) Earnings Expected to Grow: Should You Buy? (Zacks)
Oct-22-25 07:45AM	Boston Scientific (BSX) Q3 Earnings and Revenues Top Estimates (Zacks)
Oct-21-25 12:13PM	Will Rising Costs Hurt HCA Healthcare Q3 Earnings? Key Estimates Here (Zacks)
Oct-20-25 12:10PM	Will Envista (NVST) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Oct-16-25 01:16PM	Molina Healthcare Set for Q3 Earnings: Revenue Gains, But Profit Pains (Zacks)
Oct-15-25 01:52PM	Will Rising Costs Hurt Elevance's Q3 Earnings Despite Higher Premiums? (Zacks)
11:40AM	NVST or ABT: Which Is the Better Value Stock Right Now? (Zacks)
Oct-09-25 08:21AM	Envista added to Tactical Outperform list at Evercore ISI (TipRanks)
Oct-07-25 12:30PM	Nyxoah Shares Rise on First U.S. Commercial Use of Genio System (Zacks)
Oct-06-25 10:16AM	ICCM Shares Rise as FDA Clears ProSense for Breast Cancer Treatment (Zacks)
12:33AM	3 Small-Cap Stocks That Fall Short (StockStory)
Sep-30-25 04:15PM	Envista Schedules Third Quarter 2025 Earnings Call (PR Newswire)
Sep-29-25 09:40AM	Here's Why Envista (NVST) is a Strong Value Stock (Zacks)
08:22AM	Bio-Techne Stock Climbs on Advances in Spatial Biology Solutions (Zacks)
08:07AM	HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis (Zacks)
Sep-26-25 11:40AM	NVST vs. ABT: Which Stock Is the Better Value Option? (Zacks)
09:21AM	GEHC Inks License Agreement With Lantheus for Prostate Imaging Agent (Zacks)
08:41AM	Growing Diagnostics Arm Supports ABT Stock, Macro Issues Ail (Zacks)
Sep-25-25 12:54PM	TMDX Partners With Mercedes-Benz to Launch Organ Transport Network (Zacks)
09:31AM	National Vision Gains 166.5% in a Year: What's Driving the Rally? (Zacks)
09:24AM	Masimo Completes Divestment of Consumer Audio Business to HARMAN (Zacks)
Sep-24-25 08:56AM	Medtronic Receives FDA Nod for Altaviva Device: Stock to Gain? (Zacks)
Sep-23-25 01:15PM	STXS Stock Gains as Erasmus Medical Adopts Its Genesis Robotic System (Zacks)
01:11PM	Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now (Zacks)
08:21AM	Here's Why You Should Add Inogen Stock to Your Portfolio Now (Zacks)
Sep-22-25 12:33PM	Stryker Expands R&D Facility in India to Boost Medtech Innovation (Zacks)
12:27PM	Reasons to Hold AngioDynamics Stock in Your Portfolio for Now (Zacks)
09:46AM	Reasons to Retain Cooper Companies Stock in Your Portfolio for Now (Zacks)
Sep-19-25 07:34AM	SGHT Shares Rise on Meta-Analysis Showing OMNI's Long-Term Benefits (Zacks)
Sep-18-25 10:14AM	Here's Why You Should Hold Accuray Stock in Your Portfolio for Now (Zacks)
10:05AM	SYK Partners With Siemens Healthineers to Boost Stroke, Aneurysm Care (Zacks)
08:43AM	Alcon's UNITY VCS Shows Superior Efficiency in Studies, Stock Up (Zacks)
Sep-17-25 10:41AM	BWAY Shares Gain on FDA Nod for Accelerated Deep TMS Depression Care (Zacks)
08:52AM	LH Stock Rises on Acquisition of BioReference Health's Select Assets (Zacks)
Sep-16-25 10:26AM	ISRG Stock Dips Despite Introducing Real-Time Insights on da Vinci 5 (Zacks)
09:34AM	GEHC Eyes icometrix Buyout to Strengthen Neurology Imaging Portfolio (Zacks)
Sep-15-25 12:34PM	MMSI Stock Falls Despite CE Mark Win for Embosphere in Knee OA Care (Zacks)
09:01AM	QGEN Stock Gains From CE-IVDR Certification for QIAstat-Dx Portfolio (Zacks)

Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. It operates through the Specialty Products and Technologies, and Equipment and Consumables segments. The Specialty Products and Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment and Consumables segments develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems, handpieces and associated consumables, treatment units and other dental practice equipment, endodontic systems and related consumables, restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. It offers dental consumables, equipment, and services to dental professionals. The company was founded in 2018, and is headquartered in Brea, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Reis Mischa	SVP, Strategy & Bus. Dev.	Feb 10 '26	Option Exercise	17.25	9,675	166,916	38,016	Feb 11 05:15 PM
Reis Mischa	SVP, Strategy & Bus. Dev.	Feb 10 '26	Sale	30.00	9,675	290,250	32,382	Feb 11 05:15 PM
Reis Mischa	Officer	Feb 10 '26	Proposed Sale	30.00	9,675	290,250		Feb 10 12:40 PM
Reis Mischa	SVP, Strategy & Bus. Dev.	Aug 25 '25	Sale	21.60	15,000	324,000	32,382	Aug 27 04:09 PM
Reis Mischa	Officer	Aug 25 '25	Proposed Sale	21.60	15,000	324,000		Aug 25 11:33 AM

EW

Edwards Lifesciences Corp

NVST

Envista Holdings Corp

Upgrade your FINVIZ experience